Form D · Business Services
Ascent Pharma Solutions Inc
Teaneck, NJ · CIK 0001511734
Offering snapshot reported Feb 1, 2011 · SEC filing
- Reported sold
- Yet to sell Offering amount: $600K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 1, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-154691
Source: Form D, filed Feb 1, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ramil Cabela | Director, Executive |
| Maria Esguerra Agcaoili | Director, Executive |
Issuer details
Industry: Business Services (See others in industry)
Address:
323 Willow Street Suite 2 J
Teaneck, NJ, 07666
Teaneck, NJ, 07666